| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $322,800,304 ) (Continued on the next page) |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI165820 | Predictive fitness models for influenza vaccine strain selection | 001 | 3 | NIH | 5/21/2024 | $60,232 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI165820 | Predictive fitness models for influenza vaccine strain selection | 000 | 3 | NIH | 12/13/2023 | $542,099 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS047229 | Impairment of Ischemia-induced Vascular Functions by PS1 FAD Mutants | 001 | 18 | NIH | 4/10/2024 | $47,938 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES032552 | The interplay of early life exposure to environmental pollutants and folate system in the etiology of autistic behaviors | 003 | 3 | NIH | 5/6/2024 | $329,909 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS047229 | Impairment of Ischemia-induced Vascular Functions by PS1 FAD Mutants | 002 | 18 | NIH | 5/1/2024 | $20,545 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS047229 | Impairment of Ischemia-induced Vascular Functions by PS1 FAD Mutants | 000 | 18 | NIH | 12/29/2023 | $496,508 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS047229 | Impairment of Ischemia-induced Vascular Functions by PS1 FAD Mutants | 000 | 18 | NIH | 12/29/2023 | $119,848 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ONE GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K01DK128387 | The role of Nrf2 in beta cell expansion during pregnancy | 000 | 3 | NIH | 10/27/2023 | $131,490 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES032552 | The interplay of early life exposure to environmental pollutants and folate system in the etiology of autistic behaviors | 001 | 3 | NIH | 1/9/2024 | $657,908 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31NS130909 | Determining the Interacting Effects of GBA, SNCA, and APOE on a-Synuclein Pathology Severity in Dementia with Lewy Bodies and Parkinson's Disease | 001 | 2 | NIH | 5/7/2024 | $1,280 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31NS130909 | Determining the Interacting Effects of GBA, SNCA, and APOE on a-Synuclein Pathology Severity in Dementia with Lewy Bodies and Parkinson's Disease | 000 | 2 | NIH | 12/11/2023 | $46,094 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21MH131900 | Mesoscale dynamics underlying expectation bias in the orbitofrontal cortex | 001 | 2 | NIH | 7/5/2024 | $21,049 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21MH131900 | Mesoscale dynamics underlying expectation bias in the orbitofrontal cortex | 000 | 2 | NIH | 11/8/2023 | $189,441 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R34MH128502 | Telehealth Adaptation of Group and Family-Based Cognitive Behavioral Therapy for Youth at Risk for Psychosis | 000 | 2 | NIH | 1/4/2024 | $228,680 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R37CA269982 | Promoting immunity against acute myeloid leukemia through Fc effector-optimized antibody inhibitory of MICA/B shedding | 001 | 2 | NIH | 4/17/2024 | $24,642 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R37CA269982 | Promoting immunity against acute myeloid leukemia through Fc effector-optimized antibody inhibitory of MICA/B shedding | 000 | 2 | NIH | 11/28/2023 | $443,557 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI176069 | Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity | 001 | 2 | NIH | 5/21/2024 | $20,475 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI176069 | Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity | 000 | 2 | NIH | 1/19/2024 | $184,275 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21CA270702 | Exploring ovarian-derived hormone STC1 as the mediator of the protective effect of breast feeding against breast cancer. | 001 | 2 | NIH | 4/17/2024 | $11,852 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA274967 | Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer | 002 | 2 | NIH | 7/8/2024 | $114,678 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA274967 | Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer | 001 | 2 | NIH | 4/17/2024 | $35,698 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA274967 | Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer | 000 | 2 | NIH | 2/28/2024 | $642,573 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K99MH137315 | Neural Mechanisms and Neuromodulation of Affective States | 000 | 1 | NIH | 7/22/2024 | $127,305 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AR084632 | Regulation of Muscle Stem Cells by Netrin Signaling | 000 | 1 | NIH | 7/23/2024 | $223,080 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01OH012543 | Filtered eyewear to prevent light-induced melatonin suppression while maintaining visual performance and alertness in night-shift working nurses | 00 | 2 | CDC | 6/13/2024 | $668,366 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ONE GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES034864 | Cardiometabolic diseases in the World Trade Center general responder cohort and the role of subsequent environmental exposures | 000 | 2 | NIH | 10/18/2023 | $474,332 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA271604 | Modeling Best Approaches for Cardiovascular Disease Prevention in Cancer Survivors | 001 | 2 | NIH | 4/16/2024 | $34,937 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA271604 | Modeling Best Approaches for Cardiovascular Disease Prevention in Cancer Survivors | 000 | 2 | NIH | 12/6/2023 | $628,865 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F30AG079492 | The regulation of the microglial response to amyloid-beta plaques by the polycomb repressive complex 2 | 001 | 2 | NIH | 4/30/2024 | $1,280 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F30AG079492 | The regulation of the microglial response to amyloid-beta plaques by the polycomb repressive complex 2 | 000 | 2 | NIH | 11/15/2023 | $46,094 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI174216 | Comprehensive genomic and inflammatory profiling of vaccine-associated myocarditis | 001 | 2 | NIH | 5/9/2024 | $21,125 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI174216 | Comprehensive genomic and inflammatory profiling of vaccine-associated myocarditis | 000 | 2 | NIH | 11/3/2023 | $190,125 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL172363 | Advanced multi-parametric 18F-FDG PET and MRI imaging parameters of response to immune suppressant therapy in patients with active cardiac sarcoidosis | 000 | 1 | NIH | 7/19/2024 | $827,356 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UM1AI173380 | Systems Biology of Early Atopy (SUNBEAM) Analysis and Bioinformatics Center | 001 | 2 | NIH | 4/17/2024 | $340,003 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UM1AI173380 | Systems Biology of Early Atopy (SUNBEAM) Analysis and Bioinformatics Center | 000 | 2 | NIH | 11/6/2023 | $3,059,996 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DC020980 | Mechanisms of anosmia and brain infection in a genetic mouse model of COVID-19 | 000 | 1 | NIH | 12/5/2023 | $731,611 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI174902 | Integration of adjuvant derived nanoparticles and engineered mRNA for HIV vaccine discovery | 002 | 2 | NIH | 7/19/2024 | $62,718 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI174902 | Integration of adjuvant derived nanoparticles and engineered mRNA for HIV vaccine discovery | 001 | 2 | NIH | 5/14/2024 | $75,149 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI174902 | Integration of adjuvant derived nanoparticles and engineered mRNA for HIV vaccine discovery | 000 | 2 | NIH | 11/3/2023 | $676,348 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21CA286309 | Targeting the Androgen Receptor to Sensitize Bladder Cancer to Immune Check Point Blockade. | 000 | 1 | NIH | 12/22/2023 | $237,023 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U24NS135391 | New York City Collaborative Regional Coordinating Center (NYCC-RCC) | 000 | 1 | NIH | 12/11/2023 | $495,616 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K08DA060084 | Cannabinoid Receptor Type 2 Agonist as Potential Therapy for Neuroinflammation in HIV-1 Associated Neurocognitive Disorders | 000 | 1 | NIH | 12/29/2023 | $194,940 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R38HL172261 | Mount Sinai StARR Program - NHLBI | 000 | 1 | NIH | 1/9/2024 | $225,417 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL171676 | A randomized trial of perception of airflow limitation training to improve outcomes for older adults with asthma | 000 | 1 | NIH | 12/21/2023 | $779,264 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01EB035491 | Engineering pluripotent stem cells to evade and promote immunity | 001 | 1 | NIH | 6/6/2024 | $47,490 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01EB035491 | Engineering pluripotent stem cells to evade and promote immunity | 000 | 1 | NIH | 12/15/2023 | $571,302 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH131655 | A Confirmatory Efficacy Study of Interoceptive Exposure for Adolescents with Low Weight Eating Disorders | 001 | 2 | NIH | 7/17/2024 | $78,244 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH131655 | A Confirmatory Efficacy Study of Interoceptive Exposure for Adolescents with Low Weight Eating Disorders | 000 | 2 | NIH | 1/19/2024 | $704,199 |
| 2024 | 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R37CA246239 | Potentiating Checkpoint Blockade by Cross-Priming Tumor-Reactive T cells with In Situ Vaccination | 001 | 5 | NIH | 4/17/2024 | $19,388 |
|